Pharmacological therapy in patients with osteoarthritis and metabolic disorders: focus on diacerein
Background. Osteoarthritis (OA) is the most common age-related degenerative joint disease and a leading cause of pain and disability in the ageing population. The study aimed to analyze current recommendations and literature data on approaches to OA treatment in patients with comorbidities and metab...
Saved in:
Main Authors: | O.V. Kuryata, M.M. Grechanyk |
---|---|
Format: | Article |
Language: | English |
Published: |
Zaslavsky O.Yu.
2025-03-01
|
Series: | Bolʹ, Sustavy, Pozvonočnik |
Subjects: | |
Online Access: | https://pjs.zaslavsky.com.ua/index.php/journal/article/view/453 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Diacerein in the treatment of osteoarthritis in patients with comorbidity
by: E. P. Sharapova, et al.
Published: (2018-12-01) -
Efficacy and safety of diacerein in patients with knee osteoarthritis
by: L. I. Alekseeva, et al.
Published: (2017-09-01) -
Pleiotropic effects of diacerein in comorbid patients with osteoarthritis
by: I. B. Belyaeva, et al.
Published: (2022-08-01) -
Diacerein for osteoarthritis: An open-label comparative trial
by: L. V. Luchikhina, et al.
Published: (2016-03-01) -
KNEE OSTEOARTHRITIS AND METABOLIC SYNDROME: NEW APPROACHES TO THERAPY
by: L. I. Alekseeva, et al.
Published: (2018-05-01)